BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6375256)

  • 1. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
    Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight C1q-precipitins in hypocomplementemic vasculitis-urticaria syndrome: partial purification and characterization as immunoglobulin.
    Marder RJ; Burch FX; Schmid FR; Zeiss CR; Gewurz H
    J Immunol; 1978 Aug; 121(2):613-8. PubMed ID: 28369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases.
    Wisnieski JJ; Jones SM
    J Rheumatol; 1992 Jun; 19(6):884-8. PubMed ID: 1404125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus.
    Anderson CL; Stillman WS
    J Clin Invest; 1980 Aug; 66(2):353-60. PubMed ID: 6995484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
    Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
    J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune complexes in systemic sclerosis; detection by C1q binding, K-cell inhibition and Raji cell radioimmunoassays.
    Hughes P; Cunningham J; Day M; Fitzgerald JC; French MA; Wright JK; Rowell NR
    J Clin Lab Immunol; 1983 Mar; 10(3):133-8. PubMed ID: 6601718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
    Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
    Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities.
    Mårtensson U; Sjöholm AG; Sturfelt G; Truedsson L; Laurell AB
    Scand J Immunol; 1992 Jun; 35(6):735-44. PubMed ID: 1604245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin binds to C1q: possible mechanisms for their co-precipitation in cryoglobulins from patients with systemic lupus erythematosus.
    Kono I; Sakurai T; Kabashima T; Yamane K; Kashiwagi H
    Clin Exp Immunol; 1983 May; 52(2):305-10. PubMed ID: 6602675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.